A Phase II Trial of Xevinapant in Combination with Post-Operative Cisplatin and Radiotherapy for High Risk Head and Neck Cancer

被引：0
|
作者：
Yu, Y. [1 ]
Ganly, I. [2 ]
Sherman, E. [3 ]
Lee, N. Y. [4 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
123
引用
收藏
页码：E25 / E25
页数：1
相关论文
共 50 条
  • [1] Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer
    Ferris, R. L.
    Geiger, J. L.
    Trivedi, S.
    Schmitt, N. C.
    Heron, D. E.
    Johnson, J. T.
    Kim, S.
    Duvvuri, U.
    Clump, D. A.
    Bauman, J. E.
    Ohr, J. P.
    Gooding, W. E.
    Argiris, A.
    ANNALS OF ONCOLOGY, 2016, 27 (12) : 2257 - 2262
  • [2] Phase II feasibility trial of a 3-week cycle of cisplatin plus radiation for post-operative high-risk head and neck cancer in a Japanese population.
    Kiyota, N.
    Tahara, M.
    Okano, S.
    Kawashima, M.
    Matsuura, K.
    Onozawa, Y.
    Nibu, K.
    Hayashi, R.
    Yoshimura, K.
    Ohtsu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Combination of post-operative radiotherapy and cetuximab for high-risk cutaneous squamous cell cancer of the head and neck: A propensity score analysis
    Palmer, Joshua D.
    Schneider, Charles J.
    Hockstein, Neil
    Hanlon, Alexandra L.
    Silberg, Jordan
    Strasser, Jon
    Mauer, Elizabeth A.
    Dzeda, Michael
    Witt, Robert
    Raben, Adam
    ORAL ONCOLOGY, 2018, 78 : 102 - 107
  • [4] Phase II Feasibility Trial of Adjuvant Chemoradiotherapy with 3-weekly Cisplatin for Japanese Patients with Post-operative High-risk Squamous Cell Carcinoma of the Head and Neck
    Kiyota, Naomi
    Tahara, Makoto
    Okano, Susumu
    Kawashima, Mitsuhiko
    Matsuura, Kazuto
    Onozawa, Yuske
    Nibu, Kenichi
    Hayashi, Ryuichi
    Yoshimura, Kenichi
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (10) : 927 - 933
  • [5] Pre and post-operative radiotherapy in squamous cell carcinoma of head and neck cancer
    Saunders, MI
    ORAL ONCOLOGY, 2005, 1 (01) : 53 - 53
  • [6] Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial
    Magrini, Stefano Maria
    Buglione, Michela
    Corvo, Renzo
    Pirtoli, Luigi
    Paiar, Fabiola
    Ponticelli, Pietro
    Petrucci, Alessia
    Bacigalupo, Almalina
    Crociani, Monica
    Lastrucci, Luciana
    Vecchio, Stefania
    Bonomo, Pierluigi
    Pasinetti, Nadia
    Triggiani, Luca
    Cavagnini, Roberta
    Costa, Loredana
    Tonoli, Sandro
    Maddalo, Marta
    Grisanti, Salvatore
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 427 - +
  • [7] Post-operative concurrent chemo-radiotherapy versus post-operative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: A randomized phase III trial (Trans Tasman Radiation Oncology Group 05.01 Trial; POST study).
    Porceddu, Sandro Virgilio
    Poulsen, Michael
    Bressel, Mathias
    Stoneley, Adam
    Veness, Michael
    Kenny, Lizbeth M.
    Wratten, Christopher
    Corry, June
    Cooper, Stephen
    Fogarty, Gerald
    Collins, Marnie
    Collins, Michael
    Macann, Andrew
    Milross, Christopher
    Penniment, Michael Gordon
    Panizza, Benedict
    Rischin, Danny
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck (JCOG1008).
    Kiyota, Naomi
    Tahara, Makoto
    Fujii, Hirofumi
    Yamazaki, Tomoko
    Mitani, Hiroki
    Iwae, Shigemichi
    Fujimoto, Yasushi
    Onozawa, Yusuke
    Hanai, Nobuhiro
    Ogawa, Takenori
    Hara, Hiroki
    Monden, Nobuya
    Shimura, Eiji
    Minami, Shujiro
    Fujii, Takashi
    Tanaka, Kaoru
    Kodaira, Takeshi
    Mizusawa, Junki
    Nakamura, Kenichi
    Hayashi, Ryuichi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Cetuximab and radiotherapy versus cisplatin and radiotherapy for locally-advanced head and neck cancer: a randomized phase II trial
    Vozy, A.
    Cuenca, X.
    ONCOLOGIE, 2016, 18 (06) : 429 - 430
  • [10] Decreasing the time from head and neck cancer surgery to post-operative radiotherapy in a regional cancer centre
    Abdulla, Mohamed
    Davies, Rhian Sian
    Brisk, Robert
    Harries, Emma
    Rolles, Martin
    Banner, Russell
    EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 : 5 - 5
12345